Compare Oriental Aromat. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -23.01% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 3.82% signifying low profitability per unit of shareholders funds
Flat results in Mar 26
With ROCE of 3.5, it has a Fair valuation with a 1.5 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0% of the company
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 1,144 Cr (Micro Cap)
355.00
42
0.14%
0.58
0.50%
1.76
Total Returns (Price + Dividend) 
Latest dividend: 0.5036324786324786 per share ex-dividend date: Aug-08-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Oriental Aromatics Ltd Upgraded to Hold on Technical and Valuation Improvements
Oriental Aromatics Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and valuation metrics despite ongoing challenges in financial performance. The company’s Mojo Score has risen to 51.0, signalling a more balanced outlook amid mixed fundamentals and market trends.
Read full news article
Oriental Aromatics Ltd Technical Momentum Shifts to Bullish Amid Mixed Returns
Oriental Aromatics Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, supported by a series of positive signals across key indicators such as MACD, Bollinger Bands, and moving averages. This technical upgrade comes alongside a recent Mojo Grade improvement from Sell to Hold, signalling a cautious yet optimistic outlook for this micro-cap specialty chemicals player.
Read full news article
Oriental Aromatics Ltd Valuation Shifts Signal Renewed Price Attractiveness
Oriental Aromatics Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by changes in its price-to-earnings and price-to-book value ratios. This development invites a closer examination of the company’s current price attractiveness relative to its historical averages and peer group within the specialty chemicals sector.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
26-May-2026 | Source : BSEEarnings Call Transcript
Announcement under Regulation 30 (LODR)-Newspaper Publication
21-May-2026 | Source : BSESubmission of Newspaper publication of Audited Standalone and Consolidated Financial Results
Announcement under Regulation 30 (LODR)-Investor Presentation
21-May-2026 | Source : BSEEarnings Presentation for the Quarter and Year ended 31st March 2026
Corporate Actions 
No Upcoming Board Meetings
Oriental Aromatics Ltd has declared 10% dividend, ex-date: 08 Aug 25
Oriental Aromatics Ltd has announced 5:10 stock split, ex-date: 13 Dec 18
Oriental Aromatics Ltd has announced 1:1 bonus issue, ex-date: 13 Dec 18
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 4 FIIs (0.0%)
Shyamal Anil Bodani (37.08%)
None
19.05%
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 11.54% vs 16.94% in Mar 2025
YoY Growth in quarter ended Mar 2026 is 180.99% vs -85.97% in Mar 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 9.79% vs 7.10% in Sep 2024
Growth in half year ended Sep 2025 is -95.19% vs 811.60% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 10.86% vs 8.90% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -102.07% vs 3,357.43% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 11.04% vs 10.98% in Mar 2025
YoY Growth in year ended Mar 2026 is -90.36% vs 277.25% in Mar 2025






